Syndax Pharmaceuticals Inc
SNDX· Nasdaq
SNDXSyndax Pharmaceuticals Inc
Filed Mar 14, 2017 · 10-K · 73 days after period end · 0001193125-17-081863
| Metric | Q4 2016 | Q4 2015 |
|---|---|---|
| Revenue | $305.00K | — |
| Net Income | -$10.82M | -$5.26M |
| EPS Diluted | -$0.59 | -$105.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 14, 2017 · 73 d after period end
